Key Facts
• July 29, 2025: Genky Drugstores announced its financial results.
• Annual sales for the fiscal year ending June 2025 reached 200.7 billion yen, an 8.6% increase.
• Net profit rose 11.7% year-on-year to 7 billion yen, marking record highs.
• Food sales accounted for over 70% of total revenue, driving growth.
• Discount strategies for fresh food and private brand expansion boosted profitability.
• CEO Kenichi Fujinaga highlighted competitive pricing as a key success factor.
• The company anticipates continued revenue and profit growth in fiscal year 2026.
Summary
Genky Drugstores, based in Sakai City, reported record-breaking financial results for the fiscal year ending June 2025. Annual sales surpassed 200 billion yen for the first time, reaching 200.7 billion yen, an 8.6% increase from the previous year. Net profit also hit a historic high of 7 billion yen, up 11.7%. CEO Kenichi Fujinaga attributed this success to the growing share of food sales, which now account for over 70% of total revenue. The company’s strategy of offering discounted fresh food and expanding private brand products resonated with cost-conscious consumers amid rising prices. Looking ahead, Genky Drugstores expects further growth in both revenue and profit for fiscal year 2026.
